Settling the Score: Friday’s results

24 Comments

Zack Greinke put any concerns over his elbow to rest in his Dodgers’ debut last night, as he tossed 6 1/3 innings of shutout ball in a 3-0 win over the Pirates in front of a packed house at Dodger Stadium.

Greinke allowed just two hits on the night while striking out six and walking none. The $147 million man retired 14 consecutive batters between a second-inning single by Neil Walker and a single by Andrew McCutchen with one out in the seventh. McCutchen was the final batter he faced on the evening. Heck, Greinke even singled and did a takeout slide to break up a double play. Pretty good night all around.

While the Dodgers’ offense has been slow to come around thus far, their pitchers have allowed just four runs in 36 innings through the first four games. Yes, that’s a 1.00 ERA. And they’ll have ace Clayton Kershaw back on the hill tonight. He may improve that ERA and also provide some thump for the lineup.

Your Friday box scores:

Padres 2, Rockies 5

Yankees 3, Tigers 8

Angels 2, Rangers 3

Cardinals 0, Giants 1

Marlins 7, Mets 5

Twins 5, Orioles 9

Nationals 0, Reds 15

Red Sox 6, Blue Jays 4

Cubs 1, Braves 4

Indians 0, Rays 4

Royals 13, Phillies 4

Diamondbacks 3, Brewers 1

Mariners 8, White Sox 7

Athletics 8, Astros 3

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.